Yoshiko Matsuda, Takeshi Watanabe, Xiao-Kang Li. Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells. Frontiers in Immunology. 2021. 12
Yoshiko Matsuda, Takahisa Hiramitsu, Xiao-kang Li, Takeshi Watanabe. Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection. Pathogens. 2020. 10. 1. 4-4
Ryoichi Imamura, Yoshiko Matsuda, Koichi Tsutahara, Norio Nonomura, Shiro Takahara. Impact of Immunoglobulin M-Type Donor-Specific Human Leukocyte Antigen-Antibody Levels in Supernatants from Cultured Peripheral Blood Mononuclear Cells as Predictors of Antibody-Mediated Rejection. Pathogens (Basel, Switzerland). 2020. 9. 9
N. Goto, Y. Matsuda, M. Takada, T. Yamamoto, M. Tsujita, T. Hiramitsu, K. Nanmoku, Y. Watarai, A. Katayama, T. Kobayashi, et al. Long-Term Outcome in Kidney Transplant Recipients with HTLV-1 Carriers. TRANSPLANTATION. 2012. 94. 10. 553-553
Y. Matsuda, Y. Watarai, T. Yamamoto, T. HIramitsu, M. Tsujita, M. Takata, K. Nanmoku, N. Goto. Impact of Body Mass Index (BMI) on the Absorption of Cyclosporin A. TRANSPLANTATION. 2012. 94. 10. 970-970
N. Goto, Y. Matsuda, M. Takada, T. Yamamoto, M. Tsujita, T. Hiramitsu, K. Nanmoku, Y. Watarai, A. Katayama, T. Kobayashi, et al. Long-Term Outcome in Kidney Transplant Recipients with HTLV1 Carriers. TRANSPLANTATION. 2012. 94. 10. 362-362
Y. Matsuda, Y. Watarai. A Study of Renal Transplant for Patients with Neurogenic Bladder. TRANSPLANTATION. 2012. 94. 10. 926-926
T. Hiramitsu, Y. Watarai, T. Yamamoto, Y. Matsuda, M. Takata, M. Tsujita, N. Goto, K. Nanmoku, K. Uchida. Do Calcineurin Inhibitors Influence the Serum Concentrations of Mizoribine?. TRANSPLANTATION. 2012. 94. 10. 975-975
Antibody Repertoire and graft outcome following solid organ transplantation
Frontiers in immunology 2017
講演・口頭発表等 (19件):
Comparison Of Igg And Igm Type B Cell Receptor-mediated Mtor Phosphorylation Signal
(American Transplant congress 2022)
New Everolimus Administration Targeting The Prevention Of The Development Of Antibody-mediated Rejection Considering The Comparison Of Growth And Survival In Igg And Igm Memory B Cells
(American Transplant congress 2020)
Effect of Everolimus on IgM/IgG memory B cell growth and survival in vitro and applications for effective administration in clinical practice
(American Transplant Congress 2019)